Key technologies and capabilities for this role
Common questions about this position
This is a full-time role, Monday through Friday, with an expectation of 2–3 in-office days per week and additional on-site presence as needed. The individual must reside in the San Diego area and be able to commute to corporate offices.
This information is not specified in the job description.
The role requires strategic thinking to identify and evaluate partnership opportunities, cross-functional collaboration with departments like Marketing, Product Development, and Finance, and expertise in deal execution including due diligence, negotiation, and transaction close, with a focus on informatics and software-driven partnerships.
Illumina fosters a culture where every person in every role has the opportunity to make a difference, surrounded by extraordinary people, inspiring leaders, and world-changing projects, enabling employees to do more and become more than they thought possible.
Strong candidates will have experience leading end-to-end deal execution, developing business cases in cross-functional settings, monitoring market activity, supporting negotiations, and building internal relationships, particularly in informatics and software partnerships.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.